Welcome to The Visible Embryo
Home-- -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- -Contact
 

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than one million visitors each month.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human. The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform


The World Health Organization (WHO) has created a new Web site to help researchers, doctors and
patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!



Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

 

Pregnancy Timeline by SemestersFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Google Search artcles published since 2007
 
 

Home | Pregnancy Timeline | News Alerts |News Archive Sep 2, 2014

Proteolysis breaks down proteins into smaller polypeptides or amino acids.
Some drugs that affect cell membranes also increase the type of
proteins cut by rhomboid proteases.

 






WHO Child Growth Charts

 

 

 

How NSAIDs, like aspirin, affect tissue membranes

Researchers have found that three commonly used NSAIDs (nonsteroidal anti-inflammatory drugs), work by altering enzymes in cell membranes.

The finding suggests that if taken at higher-than-approved doses or even over long periods of time, prescription-level NSAIDs (and related drugs that affect cell membranes) can produce wide-ranging and unwanted side effects.

A summary of their results is published online in the journal Cell Reports.


"When drug designers think about possible side effects, they tend to think about proteins similar to those proteins being targeting by the new drug.

"But our group has found that drugs that affect cell membranes can alter proteins totally unrelated to the drug target."

Sinisa Urban, Ph.D., associate professor of molecular biology and genetics at the Johns Hopkins University School of Medicine, and a Howard Hughes Medical Institute investigator.


Working with Syed Moin PhD, Urban's project began as an investigation into the "cellular scissors" embedded within a cell membrane. Cellular scissors known as rhomboid proteases. Rhomboid proteases cut proteins which are then released from the membrane. Half a protein might exit the cell and act as a signal to another cell or both halves might end up leaking into the cell and being completely degraded without any function. It all depends on the protein and where it is cut.

Why is this important? Proteins are known to play roles in everything from malaria to Parkinson's disease.

Researchers had already found out that rhomboid proteases tend to cut proteins whose structures are unstable. While some proteins are inherently more stable than others, the cell membrane itself can physically support unstable proteins embedded within it. So, Urban went about changing the physical properties of a cell membrane "habitat" to see if such changes would allow unintended proteins to be cut up by the proteases.


Urban treated human cells with two chemicals to see if either made the membranes more flexible or distorted. When these types of distortion did occur — rhomboid proteases began cutting proteins not normally cut.

Amyloid-beta precursor protein (APP) and Delta, a signaling protein were two such proteins cut in addition to "client" or expected protein targets of the proteases.

If gamma-secretase cuts APP at the "wrong" site on the protein, the piece of protein that is generated clumps in the brain causing Alzheimer's.


Many drugs end up in the cell membrane. Certain prescription-only NSAIDs repair the function of gamma-secretase, an enzyme with more than 100 different protein clients the most famous one being APP. Some prescription-level NSAIDs, like flurbiprofen (which treats serious arthritis) make gamma-secretase less likely to cut the APP protein at the wrong site.

For over-the-counter NSAIDS like aspirin, ibuprofen and naproxen, the range of client proteins cut by rhomboid proteases increases only slightly, if at all.


In order to find out how NSAIDs actually are affecting cell membranes, Urban used an instrument that measures the melting temperature of fat.

Membranes are composed primarily of fat molecules, and heat can make membranes as fluid as melted butter. The same way solid shortening becomes liquid when heated, so can membrane fat molecules "melt."

A lower melting temperature produces a more flexible membrane. Researchers found that prescription-level NSAIDs that lower a membrane's melting temperature cause rhomboid proteases to cut nonclient proteins.


One of the benefits of this study is that the same methods used to measure the melting temperature of membrane molecules (which makes them more flexible) can be used to test new drugs. Adds Urban: "Now we can use rhomboid proteases as predictors of a drug's possible effects on a membrane and its enzymes."

Highlights
•Rhomboid enzymes catalyze proteolysis of specific protein targets in the membrane
•Perturbing cell membranes pharmacologically leads rhomboid to cleave nonsubstrates
•Several γ-secretase-modulating drugs also provoke rhomboid cleavage of nonsubstrates
•Membranes guide rhomboid specificity but are vulnerable to off-target drug effects

Summary
Rhomboid proteases are integral membrane enzymes that regulate cell signaling, adhesion, and organelle homeostasis pathways, making substrate specificity a key feature of their function. Interestingly, we found that perturbing the membrane pharmacologically in living cells had little effect on substrate processing but induced inappropriate cleavage of nonsubstrates by rhomboid proteases. A subclass of drugs known to modulate γ-secretase activity acted on the membrane directly and induced nonsubstrate cleavage by rhomboid proteases but left true substrate cleavage sites unaltered. These observations highlight an active role for the membrane in guiding rhomboid selectivity and caution that membrane-targeted drugs should be evaluated for cross-activity against membrane-resident enzymes that are otherwise unrelated to the intended drug target. Furthermore, some γ-secretase-modulating activity or toxicity could partly result from global membrane effects.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

On the Web
Link to article (live after embargo lifts): http://dx.doi.org/10.1016/j.celrep.2014.07.039

This work was supported by grants from the Howard Hughes Medical Institute, the David and Lucile Packard Foundation, and the National Institute of Allergy and Infectious Diseases (AI066025).

Return to top of page